- increased bone mineral density / IMPC
- decreased circulating calcium level / IMPC
- increased body length / IMPC
- abnormal gait / IMPC
- limb grasping / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- increased lean body mass / IMPC
- improved glucose tolerance / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating creatinine level / IMPC
- increased blood urea nitrogen level / IMPC
- decreased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral content / IMPC
- decreased bone trabecula number / IMPC
- increased bone trabecular spacing / IMPC
C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:13214 |
International strain name | C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0633_5_D12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Acbd5tm1b(EUCOMM)Wtsi |
Gene/Transgene symbol | Acbd5 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0633_5_D12. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- limb grasping / IMPC
- increased lean body mass / IMPC
- decreased circulating serum albumin level / IMPC
- increased blood urea nitrogen level / IMPC
- increased body length / IMPC
- increased bone trabecular spacing / IMPC
- decreased total body fat amount / IMPC
- increased mean platelet volume / IMPC
- decreased circulating total protein level / IMPC
- abnormal gait / IMPC
- increased bone mineral density / IMPC
- improved glucose tolerance / IMPC
- decreased bone trabecula number / IMPC
- increased bone mineral content / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating calcium level / IMPC
- increased circulating creatinine level / IMPC
- thrombocytopenia / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).